California

Claim listing

Description

California's life sciences ecosystem stands as the undisputed global leader in biomedical innovation, anchored by the dense biotechnology clusters of the San Francisco Bay Area and San Diego.

Renowned for its unparalleled concentration of pharmaceutical research and development, the Golden State serves as the primary engine for genomic medicine, synthetic biology and cell and gene therapies.

This powerhouse economy is fueled by world-class academic research institutions, including the University of California system and Stanford, which consistently bridge the gap between laboratory discovery and commercial viability.

In the medical device sector, California leads the way in precision diagnostics and wearable health technology, integrating artificial intelligence (AI) to enhance patient outcomes.

The state's robust venture capital network provides the essential access to capital that allows early-stage startups to scale into global healthcare giants.

From the digital transformation of healthcare delivery to breakthrough clinical trials, California offers a collaborative environment where industry-academia partnerships thrive. Organizations like California Life Sciences (CLS) and Biocom California further strengthen this infrastructure, advocating for policies that accelerate FDA regulatory pathways.

As a premier destination for the life sciences, California continues to shape the future of personalized medicine and global health security.

Featured Editorial

Claim Your Profile to Receive a 1500-word Editorial Article

Pharmaville offers locations the opportunity to be featured in an in-depth interview that highlights their unique strengths and advantages. These interviews showcase areas such as research expertise, clinical trial capacity, manufacturing infrastructure, and investment opportunities, and are published directly on the Pharmaville platform. This helps regions share their story with a global life science audience and position themselves as leading destinations for innovation and growth.

Regions

Healthcare and Research Infrastructure

California's life sciences ecosystem spans several major regional hubs, including the San Francisco Bay Area, San Diego, Los Angeles and Orange County. These regions are home to research universities, medical centers and biotech companies that support biomedical research, clinical trials and medical technology development. Major research institutions include the University of California, San Francisco (UCSF), Stanford University and the University of California, Berkeley in the Bay Area, along with the University of California, San Diego, Scripps Research and the Salk Institute in San Diego. Institutions such as the California Institute of Technology, the University of California, Berkeley and Stanford University rank among the top US universities for industry engagement and research collaboration.

Gallery

Government and Public Research Funding

California research organizations received 10,624 awards worth approximately $5.7 billion in combined NIH and NSF funding in 2024. California has continued to receive more NIH and NSF funding than any other US state. Between 2019 and 2024, California organizations received an average of 10,868 NIH and NSF awards per year, representing about 13% of the annual award count to US organizations. The Bay Area received $2.1 billion in NIH and NSF funding and $12.5 billion in VC, while San Diego received $1.1 billion in NIH and NSF funding and $1.9 billion in VC in 2024. The major therapeutic and research areas supported in 2024 included Alzheimer's disease and related dementias, opioids, pain management, Lyme and tick-borne diseases, antimicrobial resistance, universal flu vaccines, mental health research, ALS, clinical and translational science and AI and machine learning. In January 2026, California lawmakers introduced SB 895, a proposal to authorize a $23 billion bond to fund scientific research and research infrastructure across the state, including health and biotechnology research.

Investment and Financing

California-based life science companies attracted $63.1 billion in private capital in 2024, according to Biocom California. The total rose 32% from 2023 and was driven mainly by large corporate M&A transactions, which accounted for 67% of the year's private capital flow. VC raised totaled $13.1 billion in 2024, up 27% from the prior year. Biocom noted $10.2 billion in 148 deals for biopharma, $3.8 billion in 153 deals for healthtech, $2.5 billion in 84 deals for medtech and $2.6 billion in 83 deals for diagnostics and tools. The average venture transaction value increased from $24.8 million in 2019 to $35.3 million in 2024.

Industry Presence

California had 17,220 life science establishments in 2024. According to Biocom California, this was an increase from 16,576 establishments in 2023. In September 2025, Amgen announced a $600 million expansion of its global headquarters in Thousand Oaks, while Gilead Sciences began work on a new pharmaceutical development and manufacturing center as part of an $847 million expansion of its Foster City campus. Amgen's Thousand Oaks expansion builds on an existing Ventura County workforce of about 5,500 employees.

Big Medtech Presence

California's medical device base is substantial. Biocom California shows 92,217 jobs in the state's medical devices and equipment segment in 2024. It also reports that several manufacturing clusters remained especially important, with surgical and medical instrument manufacturing, pharmaceutical preparation manufacturing and electromedical apparatus manufacturing each employing more than 20,000 workers statewide. 141,067 life science payroll jobs in California were tied to manufacturing in 2024, and manufacturing made up 31.2% of the state's life science payroll jobs. Orange County stands out in particular, being described as a manufacturing hotspot and where manufacturing represented about half of the region's life science payroll jobs in 2024. Some notable names supporting California's medtech base include Masimo, Edwards Lifesciences and Staar Surgical.

Active Clinical Studies

According to clinicaltrials.gov, there were around 49,842 active or recruiting clinical studies listed in California as of March 9, 2026.

Location

California, USA

Get Directions

Videos

Economic Contribution

The life sciences industry generated $395.7 billion in total economic output in California in 2024. Biocom California breaks this down into $226.3 billion in direct output, $88.8 billion in indirect output and $80.6 billion in induced output. It also reports $125.7 billion in total labor income, including $65.6 billion in direct labor income, and says the sector supported 1,145,063 total jobs when multiplier effects are included. The life sciences sector's economic role extends beyond companies themselves and into supplier industries, logistics, services and household spending connected to life sciences employment. California exported approximately $8.3 billion in pharmaceutical and medical products.

Life Science Workforce

California's industry covers six major sectors: biotech, biopharma, medical devices and equipment, research and testing, scientific and research tools and food and agriculture biotechnology. The state's life sciences industry directly employed 452,455 workers in 2024. This number was down from 466,888 in 2023, reflecting a 3.1% year-over-year decline, but it also shows that the broader sector still supported 1.15 million jobs across California when indirect and induced effects are included. Biocom reported an average yearly salary of $157,532 for life sciences workers in 2024. Across each major sector, California saw 124,304 jobs in biotechnology, 116,974 in research and testing, 92,217 in medical devices and equipment, 74,421 in biopharmaceuticals, 38,561 in scientific and research tools and 5,978 in food and agriculture biotechnology. The Bay Area remained the largest regional life sciences market in 2024, with 121,604 direct life sciences jobs, while San Diego reported 60,484, Los Angeles 63,602 and Orange County 48,046.

Laboratory and Manufacturing Space

According to CBRE, the San Francisco Bay Area contains approximately 51.3 million ft2 of life sciences laboratory and R&D space while the San Diego market contains approximately 27.3 million ft2 of life sciences laboratory and R&D space, with an additional 1.6 million ft2 of laboratory space under construction. In 2025, Gilead Sciences began construction of a new pharmaceutical development and manufacturing center in Foster City as part of an $847 million campus expansion, with the facility expected to support nearly 2,500 jobs when completed. Once operational, the Gilead expansion is expected to contribute approximately $227 million in annual GDP.

Talent, Innovation and IP

California filed 4,940 life sciences patents in 2024, according to Biocom California. The labor market remains specialized and competitive, with unemployment in life science occupations averaging to 2.4%, compared with a national average of 4.2%. In 2020, universities in California awarded approximately 1,200 doctoral degrees in life sciences disciplines. Female life sciences graduates made up 62.7% of graduates across all degree levels in 2019. Hispanic and Latino graduates in life sciences fields increased by 64.5% between 2015 and 2019. In 2019, 62.7% of life sciences graduates in California were women, and the number of Hispanic and Latino graduates in life sciences fields increased by 64.5% between 2015 and 2019. California issued 45.1 life sciences patents per 1,000 individuals in science and engineering occupations in 2019. The Global Innovation Index 2025 ranks the San Jose-San Francisco cluster third globally, while Los Angeles ranks tenth and San Diego fourteenth, showcasing the concentration of research institutions, technology firms and scientific activity across California's innovation hubs.

Website

Claim Profile to Update Website

Contact

Claim Profile to Update Contact Information

Links

Claim Your Profile to Add Related Links

Downloadables

Claim Your Profile to add downloadable documentation

References

https://pharmaville.com/wp-content/uploads/2026/03/Pharmaville-California-references.pdf

California

Description

Featured Editorial

Regions

Healthcare and Research Infrastructure

Gallery

Government and Public Research Funding

Investment and Financing

Industry Presence

Big Medtech Presence

Active Clinical Studies

Location

Categories

Tags

Videos

Economic Contribution

Life Science Workforce

Laboratory and Manufacturing Space

Talent, Innovation and IP

Website

Contact

Links

Downloadables

References

You May Also Be Interested In

San Francisco, California

Ontario

Newfoundland and Labrador

California

Description

Featured Editorial

Regions

Healthcare and Research Infrastructure

Gallery

Government and Public Research Funding

Investment and Financing

Industry Presence

Big Medtech Presence

Active Clinical Studies

Location

Related Events

Categories

Tags

Videos

Economic Contribution

Life Science Workforce

Laboratory and Manufacturing Space

Talent, Innovation and IP

Website

Contact

Links

Downloadables

References

Related Event

You May Also Be Interested In

San Francisco, California

Ontario

Newfoundland and Labrador